Snowden Capital Advisors LLC Raises Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Snowden Capital Advisors LLC lifted its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 15.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 5,475 shares of the company’s stock after purchasing an additional 740 shares during the period. Snowden Capital Advisors LLC’s holdings in U.S. Physical Therapy were worth $486,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of USPH. CBIZ Investment Advisory Services LLC increased its stake in shares of U.S. Physical Therapy by 59.8% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock worth $29,000 after purchasing an additional 122 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of U.S. Physical Therapy during the 4th quarter worth approximately $39,000. Venturi Wealth Management LLC increased its stake in shares of U.S. Physical Therapy by 3,200.0% during the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock worth $64,000 after purchasing an additional 704 shares during the last quarter. Lazard Asset Management LLC purchased a new stake in shares of U.S. Physical Therapy during the 4th quarter worth approximately $84,000. Finally, Pacer Advisors Inc. purchased a new stake in shares of U.S. Physical Therapy during the 4th quarter worth approximately $113,000.

Insider Transactions at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,730 shares of the company’s stock in a transaction on Friday, March 7th. The shares were sold at an average price of $82.11, for a total value of $142,050.30. Following the completion of the transaction, the chief operating officer now directly owns 7,168 shares in the company, valued at approximately $588,564.48. The trade was a 19.44% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 2.00% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on USPH. JMP Securities reiterated a “market outperform” rating and issued a $113.00 price objective on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. William Blair reiterated a “market perform” rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. StockNews.com upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Thursday, May 8th. JPMorgan Chase & Co. reduced their price objective on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating for the company in a research note on Wednesday, March 19th. Finally, Barrington Research reduced their price objective on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating for the company in a research note on Friday, February 28th. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, U.S. Physical Therapy currently has a consensus rating of “Moderate Buy” and a consensus target price of $109.00.

U.S. Physical Therapy Trading Down 2.6%

U.S. Physical Therapy stock opened at $77.36 on Thursday. The stock has a market cap of $1.18 billion, a P/E ratio of 82.30, a PEG ratio of 3.54 and a beta of 1.44. U.S. Physical Therapy, Inc. has a fifty-two week low of $62.77 and a fifty-two week high of $105.80. The firm’s fifty day moving average price is $71.96 and its 200-day moving average price is $83.49. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share for the quarter, topping the consensus estimate of $0.46 by $0.02. The firm had revenue of $183.79 million for the quarter, compared to analysts’ expectations of $176.78 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The business’s quarterly revenue was up 18.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.51 earnings per share. Equities research analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 23rd will be issued a $0.45 dividend. The ex-dividend date of this dividend is Friday, May 23rd. This represents a $1.80 annualized dividend and a dividend yield of 2.33%. U.S. Physical Therapy’s payout ratio is currently 82.57%.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.